SlideShare a Scribd company logo
Unravelling Meaningful Use Stage 3
A brief overview of what it means for Healthcare ISVs
Download Whitepaper at www.nalashaahealth.com
MEANINGFUL USE STAGE 3
For Example
 CMS will now allow providers to consume APIs to
help meet criteria.
 All providers to report on a full calendar year
reporting period (except Medicaid providers,
who would report for every 90 days in their first
year)
Comparative Study based on proposed final rule
Overview
Meaningful Use (MU) stage 3 is the next step to meaning-
ful use stage 1 and meaningful use stage 2 programs.
Most of the modifications proposed in MU3 are designed
to align with the current MU requirements and make it
more practical & flexible. That said, some of the MU2
objectives are retained as such, with small or no modifi-
cation while some have an extended scope.
Health organizations will have option to report in Stage 3 criteria in 2017. They'll be required to do so beginning in
2018, regardless of prior participation/stage of meaningful use.
MU2 modifications (2015 to 2017), major provisions
10
objectives for eligible professionals (EPs) in-
cluding one public health reporting objective,
down from 18 total objectives in prior stages.
9
objectives for eligible hospitals (EHs) and critical
access hospitals (CAHs) including one public
health reporting objective, down from 20 total objec-
tives in prior stages.
90day continuous reporting period in their first
year of eligibility
Clinical Quality Measures (CQM) reporting for both eligi-
ble professionals (EPs) and eligible hospitals/CAHs re-
mains as previously finalized.
Core MU3 objectives highlights
8 objectives for EPs, EHs, and CAHs
>60%
of measures require interoper-
ability, up from 33% in MU2.
Public health reporting with flexible options for meas-
ure selection and CQM reporting aligned with the
CMS quality reporting programs.
Finalize use of application program interfaces (APIs)
that aid development of new functionalities to build
bridges across systems. This will help patients have
unprecedented access to their health records to
make key health decisions.
45%of criteria are unchanged or minimally revised for the ambulatory settings.
42%of criteria are unchanged or minimally revised for inpatient settings.
Only need to do ~60% of proposed 2015 Edition criteria to participate in Stage 3.
Minimum requirement for MU3: Ambulatory Vs Inpatient

More Related Content

What's hot

Centricity Practice Solution MQIC Info
Centricity Practice Solution MQIC InfoCentricity Practice Solution MQIC Info
Centricity Practice Solution MQIC Info
GE Healthcare - IT
 
FDA’s Food Safety Plan Builder
FDA’s Food Safety Plan BuilderFDA’s Food Safety Plan Builder
FDA’s Food Safety Plan Builder
EMMAIntl
 
The Merit-based Incentive Payment System (MIPS)
The Merit-based Incentive Payment System (MIPS)The Merit-based Incentive Payment System (MIPS)
The Merit-based Incentive Payment System (MIPS)
Coding Institute (TCI)
 
Brenda Driscoll Resume 3-4-16
Brenda Driscoll Resume 3-4-16Brenda Driscoll Resume 3-4-16
Brenda Driscoll Resume 3-4-16
Brenda Driscoll
 
Alternative payment models (ap ms)
Alternative payment models (ap ms)Alternative payment models (ap ms)
Alternative payment models (ap ms)
alicecarlos1
 
Office Hours: Kidney Care Choices (KCC) Model - Application
Office Hours: Kidney Care Choices (KCC) Model - ApplicationOffice Hours: Kidney Care Choices (KCC) Model - Application
Office Hours: Kidney Care Choices (KCC) Model - Application
Centers for Medicare & Medicaid Services (CMS)
 
JFPS Poster
JFPS PosterJFPS Poster
Nscbl slide
Nscbl slideNscbl slide
Nscbl slide
Mmedsc Hahm
 
Observational research and registries
Observational research and registriesObservational research and registries
Observational research and registries
Satish Kumar
 
Project iHeal
Project iHealProject iHeal
Project iHeal
Sandeep Supal
 
2010 media flash key findings
2010 media flash key findings2010 media flash key findings
2010 media flash key findings
BernardOlson
 
Requirements for Dryland Systems Phase II- John Lynam
 Requirements for Dryland Systems Phase II- John Lynam Requirements for Dryland Systems Phase II- John Lynam
Requirements for Dryland Systems Phase II- John Lynam
CGIAR Research Program on Dryland Systems
 
Webinar: Comprehensive Primary Care Plus - Health IT Vendor Overview
Webinar: Comprehensive Primary Care Plus - Health IT Vendor OverviewWebinar: Comprehensive Primary Care Plus - Health IT Vendor Overview
Webinar: Comprehensive Primary Care Plus - Health IT Vendor Overview
Centers for Medicare & Medicaid Services (CMS)
 
Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...
Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...
Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...
Centers for Medicare & Medicaid Services (CMS)
 
ABCs fo ACOs and the New Track 1+ Model
ABCs fo ACOs and the New Track 1+ ModelABCs fo ACOs and the New Track 1+ Model
ABCs fo ACOs and the New Track 1+ Model
Ben Quirk
 
MACRA Reporting Options
MACRA Reporting OptionsMACRA Reporting Options
MACRA Reporting Options
Medisolv, Inc.
 
09 03 streamlining procurement processes in bangladesh
09 03 streamlining procurement processes in bangladesh09 03 streamlining procurement processes in bangladesh
09 03 streamlining procurement processes in bangladesh
Golam Kibria MadhurZa
 
Delivering Audit Integrity
Delivering Audit IntegrityDelivering Audit Integrity
Delivering Audit Integrity
SQF Institute
 
law enforcement resume-3
law enforcement resume-3law enforcement resume-3
law enforcement resume-3
Tanya Mukle
 
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
CORE Group
 

What's hot (20)

Centricity Practice Solution MQIC Info
Centricity Practice Solution MQIC InfoCentricity Practice Solution MQIC Info
Centricity Practice Solution MQIC Info
 
FDA’s Food Safety Plan Builder
FDA’s Food Safety Plan BuilderFDA’s Food Safety Plan Builder
FDA’s Food Safety Plan Builder
 
The Merit-based Incentive Payment System (MIPS)
The Merit-based Incentive Payment System (MIPS)The Merit-based Incentive Payment System (MIPS)
The Merit-based Incentive Payment System (MIPS)
 
Brenda Driscoll Resume 3-4-16
Brenda Driscoll Resume 3-4-16Brenda Driscoll Resume 3-4-16
Brenda Driscoll Resume 3-4-16
 
Alternative payment models (ap ms)
Alternative payment models (ap ms)Alternative payment models (ap ms)
Alternative payment models (ap ms)
 
Office Hours: Kidney Care Choices (KCC) Model - Application
Office Hours: Kidney Care Choices (KCC) Model - ApplicationOffice Hours: Kidney Care Choices (KCC) Model - Application
Office Hours: Kidney Care Choices (KCC) Model - Application
 
JFPS Poster
JFPS PosterJFPS Poster
JFPS Poster
 
Nscbl slide
Nscbl slideNscbl slide
Nscbl slide
 
Observational research and registries
Observational research and registriesObservational research and registries
Observational research and registries
 
Project iHeal
Project iHealProject iHeal
Project iHeal
 
2010 media flash key findings
2010 media flash key findings2010 media flash key findings
2010 media flash key findings
 
Requirements for Dryland Systems Phase II- John Lynam
 Requirements for Dryland Systems Phase II- John Lynam Requirements for Dryland Systems Phase II- John Lynam
Requirements for Dryland Systems Phase II- John Lynam
 
Webinar: Comprehensive Primary Care Plus - Health IT Vendor Overview
Webinar: Comprehensive Primary Care Plus - Health IT Vendor OverviewWebinar: Comprehensive Primary Care Plus - Health IT Vendor Overview
Webinar: Comprehensive Primary Care Plus - Health IT Vendor Overview
 
Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...
Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...
Webinar: Part D Enhanced Medication Therapy Management (MTM) Model - Proposed...
 
ABCs fo ACOs and the New Track 1+ Model
ABCs fo ACOs and the New Track 1+ ModelABCs fo ACOs and the New Track 1+ Model
ABCs fo ACOs and the New Track 1+ Model
 
MACRA Reporting Options
MACRA Reporting OptionsMACRA Reporting Options
MACRA Reporting Options
 
09 03 streamlining procurement processes in bangladesh
09 03 streamlining procurement processes in bangladesh09 03 streamlining procurement processes in bangladesh
09 03 streamlining procurement processes in bangladesh
 
Delivering Audit Integrity
Delivering Audit IntegrityDelivering Audit Integrity
Delivering Audit Integrity
 
law enforcement resume-3
law enforcement resume-3law enforcement resume-3
law enforcement resume-3
 
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
 

Similar to Meaningful Use Stage 3 Requirements

Quality Payment Program (MACRA) Proposed Rule
Quality Payment Program (MACRA) Proposed RuleQuality Payment Program (MACRA) Proposed Rule
Quality Payment Program (MACRA) Proposed Rule
Mick Brown
 
The Impact of Proposed MU Rule Changes 2015 2017
The Impact of Proposed MU Rule Changes 2015 2017The Impact of Proposed MU Rule Changes 2015 2017
The Impact of Proposed MU Rule Changes 2015 2017
MassEHealth
 
Mu stage 3 did the cms finally get it right
Mu stage 3  did the cms finally get it rightMu stage 3  did the cms finally get it right
Mu stage 3 did the cms finally get it right
CureMD
 
PQRS 101: Meeting Requirements, Avoiding Penalties
PQRS 101: Meeting Requirements, Avoiding PenaltiesPQRS 101: Meeting Requirements, Avoiding Penalties
PQRS 101: Meeting Requirements, Avoiding Penalties
athenahealth
 
Value-Based Healthcare Strategies
Value-Based Healthcare StrategiesValue-Based Healthcare Strategies
Value-Based Healthcare Strategies
Colin Bertram
 
Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015
Ben Quirk
 
Hfma 2016 10 (3) block chain technology by steve omans
Hfma 2016 10 (3) block chain technology by steve omansHfma 2016 10 (3) block chain technology by steve omans
Hfma 2016 10 (3) block chain technology by steve omans
Steve Omans
 
Delivering Care Under the MACRA Final Rule: Implementation Considerations and...
Delivering Care Under the MACRA Final Rule: Implementation Considerations and...Delivering Care Under the MACRA Final Rule: Implementation Considerations and...
Delivering Care Under the MACRA Final Rule: Implementation Considerations and...
Epstein Becker Green
 
MACRA Proposed Rule: Issues & Opportunities
MACRA Proposed Rule: Issues & OpportunitiesMACRA Proposed Rule: Issues & Opportunities
MACRA Proposed Rule: Issues & Opportunities
Polsinelli PC
 
PFS Proposed Rule 2023
PFS Proposed Rule 2023PFS Proposed Rule 2023
PFS Proposed Rule 2023
Medisolv, Inc.
 
CMS 2018 IPPS Proposed Rule
CMS 2018 IPPS Proposed RuleCMS 2018 IPPS Proposed Rule
CMS 2018 IPPS Proposed Rule
Shelby Lewis
 
MACRA
MACRAMACRA
MACRA 071916
MACRA   071916MACRA   071916
MACRA 071916
Tyler Barnett
 
Achieving meaningfuluse stage2
Achieving meaningfuluse stage2Achieving meaningfuluse stage2
Achieving meaningfuluse stage2
Tim Boucher
 
MIPS APM for ACOs: A Hybrid Reimbursement Model
MIPS APM for ACOs: A Hybrid Reimbursement ModelMIPS APM for ACOs: A Hybrid Reimbursement Model
MIPS APM for ACOs: A Hybrid Reimbursement Model
CitiusTech
 
Insights17 MIPS Proposed Rule
Insights17 MIPS Proposed RuleInsights17 MIPS Proposed Rule
Insights17 MIPS Proposed Rule
Ben Quirk
 
Meaningful Use Stage 2 Changes for Eligible Professionals
Meaningful Use Stage 2 Changes for Eligible ProfessionalsMeaningful Use Stage 2 Changes for Eligible Professionals
Meaningful Use Stage 2 Changes for Eligible Professionals
Michigan Primary Care Association
 
The March to MIPS
The March to MIPSThe March to MIPS
The March to MIPS
PYA, P.C.
 
2022 QPP MIPS Final Rule
2022 QPP MIPS Final Rule2022 QPP MIPS Final Rule
2022 QPP MIPS Final Rule
Medisolv, Inc.
 
5 Steps to MIPS
5 Steps to MIPS5 Steps to MIPS
5 Steps to MIPS
Lee Ann Dangelo
 

Similar to Meaningful Use Stage 3 Requirements (20)

Quality Payment Program (MACRA) Proposed Rule
Quality Payment Program (MACRA) Proposed RuleQuality Payment Program (MACRA) Proposed Rule
Quality Payment Program (MACRA) Proposed Rule
 
The Impact of Proposed MU Rule Changes 2015 2017
The Impact of Proposed MU Rule Changes 2015 2017The Impact of Proposed MU Rule Changes 2015 2017
The Impact of Proposed MU Rule Changes 2015 2017
 
Mu stage 3 did the cms finally get it right
Mu stage 3  did the cms finally get it rightMu stage 3  did the cms finally get it right
Mu stage 3 did the cms finally get it right
 
PQRS 101: Meeting Requirements, Avoiding Penalties
PQRS 101: Meeting Requirements, Avoiding PenaltiesPQRS 101: Meeting Requirements, Avoiding Penalties
PQRS 101: Meeting Requirements, Avoiding Penalties
 
Value-Based Healthcare Strategies
Value-Based Healthcare StrategiesValue-Based Healthcare Strategies
Value-Based Healthcare Strategies
 
Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015Meaningful Use Final Rule Updates 2015
Meaningful Use Final Rule Updates 2015
 
Hfma 2016 10 (3) block chain technology by steve omans
Hfma 2016 10 (3) block chain technology by steve omansHfma 2016 10 (3) block chain technology by steve omans
Hfma 2016 10 (3) block chain technology by steve omans
 
Delivering Care Under the MACRA Final Rule: Implementation Considerations and...
Delivering Care Under the MACRA Final Rule: Implementation Considerations and...Delivering Care Under the MACRA Final Rule: Implementation Considerations and...
Delivering Care Under the MACRA Final Rule: Implementation Considerations and...
 
MACRA Proposed Rule: Issues & Opportunities
MACRA Proposed Rule: Issues & OpportunitiesMACRA Proposed Rule: Issues & Opportunities
MACRA Proposed Rule: Issues & Opportunities
 
PFS Proposed Rule 2023
PFS Proposed Rule 2023PFS Proposed Rule 2023
PFS Proposed Rule 2023
 
CMS 2018 IPPS Proposed Rule
CMS 2018 IPPS Proposed RuleCMS 2018 IPPS Proposed Rule
CMS 2018 IPPS Proposed Rule
 
MACRA
MACRAMACRA
MACRA
 
MACRA 071916
MACRA   071916MACRA   071916
MACRA 071916
 
Achieving meaningfuluse stage2
Achieving meaningfuluse stage2Achieving meaningfuluse stage2
Achieving meaningfuluse stage2
 
MIPS APM for ACOs: A Hybrid Reimbursement Model
MIPS APM for ACOs: A Hybrid Reimbursement ModelMIPS APM for ACOs: A Hybrid Reimbursement Model
MIPS APM for ACOs: A Hybrid Reimbursement Model
 
Insights17 MIPS Proposed Rule
Insights17 MIPS Proposed RuleInsights17 MIPS Proposed Rule
Insights17 MIPS Proposed Rule
 
Meaningful Use Stage 2 Changes for Eligible Professionals
Meaningful Use Stage 2 Changes for Eligible ProfessionalsMeaningful Use Stage 2 Changes for Eligible Professionals
Meaningful Use Stage 2 Changes for Eligible Professionals
 
The March to MIPS
The March to MIPSThe March to MIPS
The March to MIPS
 
2022 QPP MIPS Final Rule
2022 QPP MIPS Final Rule2022 QPP MIPS Final Rule
2022 QPP MIPS Final Rule
 
5 Steps to MIPS
5 Steps to MIPS5 Steps to MIPS
5 Steps to MIPS
 

More from Nalashaa Healthcare Solutions

Webinar on the 21st Century Cures Act Final Rule
Webinar on the 21st Century Cures Act Final RuleWebinar on the 21st Century Cures Act Final Rule
Webinar on the 21st Century Cures Act Final Rule
Nalashaa Healthcare Solutions
 
Webinar on Using MS D365 for Hospitals During the COVID-19 Pandemic
Webinar on Using MS D365 for Hospitals During the COVID-19 PandemicWebinar on Using MS D365 for Hospitals During the COVID-19 Pandemic
Webinar on Using MS D365 for Hospitals During the COVID-19 Pandemic
Nalashaa Healthcare Solutions
 
Crm for-hc-mini - final
Crm for-hc-mini - finalCrm for-hc-mini - final
Crm for-hc-mini - final
Nalashaa Healthcare Solutions
 
The Fundamentals of Patient engagement
The Fundamentals of Patient engagementThe Fundamentals of Patient engagement
The Fundamentals of Patient engagement
Nalashaa Healthcare Solutions
 
Case management mini
Case management miniCase management mini
Case management mini
Nalashaa Healthcare Solutions
 
Oncology care model mini
Oncology care model mini Oncology care model mini
Oncology care model mini
Nalashaa Healthcare Solutions
 
Oncology Care Model - Nalashaa
Oncology Care Model - NalashaaOncology Care Model - Nalashaa
Oncology Care Model - Nalashaa
Nalashaa Healthcare Solutions
 
2019 EHR Changes for Providers and Hospitals
2019 EHR Changes for Providers and Hospitals2019 EHR Changes for Providers and Hospitals
2019 EHR Changes for Providers and Hospitals
Nalashaa Healthcare Solutions
 
CMS’s Data Element Library
CMS’s Data Element LibraryCMS’s Data Element Library
CMS’s Data Element Library
Nalashaa Healthcare Solutions
 
TEFCA- Trusted Exchange Frame work and Common Agreement
TEFCA- Trusted Exchange Frame work and Common AgreementTEFCA- Trusted Exchange Frame work and Common Agreement
TEFCA- Trusted Exchange Frame work and Common Agreement
Nalashaa Healthcare Solutions
 
Therapists' Guide- A Successful Approach to 2019 Final Rule
Therapists' Guide- A Successful Approach to 2019 Final RuleTherapists' Guide- A Successful Approach to 2019 Final Rule
Therapists' Guide- A Successful Approach to 2019 Final Rule
Nalashaa Healthcare Solutions
 
Pharmacy Benefit Managers
Pharmacy Benefit ManagersPharmacy Benefit Managers
Pharmacy Benefit Managers
Nalashaa Healthcare Solutions
 
Utilization Management in Population Health Management
Utilization Management in Population Health ManagementUtilization Management in Population Health Management
Utilization Management in Population Health Management
Nalashaa Healthcare Solutions
 
Opioid Crisis in health care industry
Opioid Crisis in health care industryOpioid Crisis in health care industry
Opioid Crisis in health care industry
Nalashaa Healthcare Solutions
 
Qualified Health Plans
Qualified Health PlansQualified Health Plans
Qualified Health Plans
Nalashaa Healthcare Solutions
 
Population Health Management
Population Health ManagementPopulation Health Management
Population Health Management
Nalashaa Healthcare Solutions
 
Home Health Grouping Model
Home Health Grouping ModelHome Health Grouping Model
Home Health Grouping Model
Nalashaa Healthcare Solutions
 
Blue Button 2.0
Blue Button 2.0Blue Button 2.0
Enabling Cloud Deployment
Enabling Cloud DeploymentEnabling Cloud Deployment
Enabling Cloud Deployment
Nalashaa Healthcare Solutions
 
Blockchain- Transforming Healthcare Ecosystem
Blockchain- Transforming Healthcare EcosystemBlockchain- Transforming Healthcare Ecosystem
Blockchain- Transforming Healthcare Ecosystem
Nalashaa Healthcare Solutions
 

More from Nalashaa Healthcare Solutions (20)

Webinar on the 21st Century Cures Act Final Rule
Webinar on the 21st Century Cures Act Final RuleWebinar on the 21st Century Cures Act Final Rule
Webinar on the 21st Century Cures Act Final Rule
 
Webinar on Using MS D365 for Hospitals During the COVID-19 Pandemic
Webinar on Using MS D365 for Hospitals During the COVID-19 PandemicWebinar on Using MS D365 for Hospitals During the COVID-19 Pandemic
Webinar on Using MS D365 for Hospitals During the COVID-19 Pandemic
 
Crm for-hc-mini - final
Crm for-hc-mini - finalCrm for-hc-mini - final
Crm for-hc-mini - final
 
The Fundamentals of Patient engagement
The Fundamentals of Patient engagementThe Fundamentals of Patient engagement
The Fundamentals of Patient engagement
 
Case management mini
Case management miniCase management mini
Case management mini
 
Oncology care model mini
Oncology care model mini Oncology care model mini
Oncology care model mini
 
Oncology Care Model - Nalashaa
Oncology Care Model - NalashaaOncology Care Model - Nalashaa
Oncology Care Model - Nalashaa
 
2019 EHR Changes for Providers and Hospitals
2019 EHR Changes for Providers and Hospitals2019 EHR Changes for Providers and Hospitals
2019 EHR Changes for Providers and Hospitals
 
CMS’s Data Element Library
CMS’s Data Element LibraryCMS’s Data Element Library
CMS’s Data Element Library
 
TEFCA- Trusted Exchange Frame work and Common Agreement
TEFCA- Trusted Exchange Frame work and Common AgreementTEFCA- Trusted Exchange Frame work and Common Agreement
TEFCA- Trusted Exchange Frame work and Common Agreement
 
Therapists' Guide- A Successful Approach to 2019 Final Rule
Therapists' Guide- A Successful Approach to 2019 Final RuleTherapists' Guide- A Successful Approach to 2019 Final Rule
Therapists' Guide- A Successful Approach to 2019 Final Rule
 
Pharmacy Benefit Managers
Pharmacy Benefit ManagersPharmacy Benefit Managers
Pharmacy Benefit Managers
 
Utilization Management in Population Health Management
Utilization Management in Population Health ManagementUtilization Management in Population Health Management
Utilization Management in Population Health Management
 
Opioid Crisis in health care industry
Opioid Crisis in health care industryOpioid Crisis in health care industry
Opioid Crisis in health care industry
 
Qualified Health Plans
Qualified Health PlansQualified Health Plans
Qualified Health Plans
 
Population Health Management
Population Health ManagementPopulation Health Management
Population Health Management
 
Home Health Grouping Model
Home Health Grouping ModelHome Health Grouping Model
Home Health Grouping Model
 
Blue Button 2.0
Blue Button 2.0Blue Button 2.0
Blue Button 2.0
 
Enabling Cloud Deployment
Enabling Cloud DeploymentEnabling Cloud Deployment
Enabling Cloud Deployment
 
Blockchain- Transforming Healthcare Ecosystem
Blockchain- Transforming Healthcare EcosystemBlockchain- Transforming Healthcare Ecosystem
Blockchain- Transforming Healthcare Ecosystem
 

Recently uploaded

Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
Vishal kr Thakur
 
Feeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptxFeeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptx
SatvikaPrasad
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
DianaRodriguez639773
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
Isha Jaiswal
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
Lift Ability
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
bkling
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
bkling
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
R3 Stem Cell
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 

Recently uploaded (20)

Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
 
Feeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptxFeeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptx
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
 
Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 

Meaningful Use Stage 3 Requirements

  • 1. Unravelling Meaningful Use Stage 3 A brief overview of what it means for Healthcare ISVs Download Whitepaper at www.nalashaahealth.com
  • 2. MEANINGFUL USE STAGE 3 For Example  CMS will now allow providers to consume APIs to help meet criteria.  All providers to report on a full calendar year reporting period (except Medicaid providers, who would report for every 90 days in their first year) Comparative Study based on proposed final rule Overview Meaningful Use (MU) stage 3 is the next step to meaning- ful use stage 1 and meaningful use stage 2 programs. Most of the modifications proposed in MU3 are designed to align with the current MU requirements and make it more practical & flexible. That said, some of the MU2 objectives are retained as such, with small or no modifi- cation while some have an extended scope. Health organizations will have option to report in Stage 3 criteria in 2017. They'll be required to do so beginning in 2018, regardless of prior participation/stage of meaningful use. MU2 modifications (2015 to 2017), major provisions 10 objectives for eligible professionals (EPs) in- cluding one public health reporting objective, down from 18 total objectives in prior stages. 9 objectives for eligible hospitals (EHs) and critical access hospitals (CAHs) including one public health reporting objective, down from 20 total objec- tives in prior stages. 90day continuous reporting period in their first year of eligibility Clinical Quality Measures (CQM) reporting for both eligi- ble professionals (EPs) and eligible hospitals/CAHs re- mains as previously finalized. Core MU3 objectives highlights 8 objectives for EPs, EHs, and CAHs >60% of measures require interoper- ability, up from 33% in MU2. Public health reporting with flexible options for meas- ure selection and CQM reporting aligned with the CMS quality reporting programs. Finalize use of application program interfaces (APIs) that aid development of new functionalities to build bridges across systems. This will help patients have unprecedented access to their health records to make key health decisions.
  • 3. 45%of criteria are unchanged or minimally revised for the ambulatory settings. 42%of criteria are unchanged or minimally revised for inpatient settings. Only need to do ~60% of proposed 2015 Edition criteria to participate in Stage 3. Minimum requirement for MU3: Ambulatory Vs Inpatient